Skip to main content
J

Jacobson Pharma Corporation Limited — Investor Relations & Filings

Ticker · 2633 HKEX Manufacturing
Open in API
Filings indexed 391 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2633

About Jacobson Pharma Corporation Limited

http://www.jacobsonpharma.com

Jacobson Pharma Corporation Limited is a pharmaceutical group specializing in the research, development, production, marketing, and distribution of medicine and drugs. The company operates through two primary segments: Generic Drugs and Branded Healthcare. Its core business focuses on the Generic Drugs segment, which involves developing and manufacturing a robust portfolio of off-patent medicines across various therapeutic categories, including cardiovascular treatments. Jacobson Pharma is committed to providing quality and affordable generic drugs, aiming to meet the needs of patients and the healthcare system. The company maintains a leading position in the regional market for generic pharmaceuticals.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2026
Regulatory Filings
2026-05-04 English
DISCLOSEABLE TRANSACTION ACCEPTANCE OF TENDER IN RELATION TO THE PROVISION OF SPECIAL INFRASTRUCTURE DEVELOPMENT AND SPECIALISED FACILITIES WORKS AT TAI PO INNOPARK
Regulatory Filings Classification · 1% confidence The document is a Hong Kong Stock Exchange announcement titled “Disclosable Transaction” detailing the acceptance of a tender for infrastructure works and its principal terms, which is a regulatory announcement under Chapter 14 of the Listing Rules. It is neither an earnings release, annual report, M&A, nor any other specific transaction type, so it defaults to a general regulatory filing. Hence, it is classified as a Regulatory Filing (RNS).
2026-04-01 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2026
Regulatory Filings Classification · 1% confidence The document is a monthly statutory return (Form FF301) filed with the Hong Kong Stock Exchange detailing movements in authorised share capital, issued shares, share options, and confirmations under Listing Rules for the month ended 31 March 2026. It is not a financial report (10-K/IR), earnings release, AGM material, or management commentary, nor does it fit specialized categories like dividend notice or M&A. This is a routine compliance/regulatory submission to the exchange, so it falls under the general “Regulatory Filings” category (RNS).
2026-04-01 English
JOINT ANNOUNCEMENT RENEWAL OF CONTINUING CONNECTED TRANSACTIONS
Regulatory Filings Classification · 1% confidence The document is a joint announcement by Jacobson Pharma Corporation Limited and JBM (Healthcare) Limited regarding the renewal of 'Continuing Connected Transactions' (Logistics and Manufacturing Services Agreements). It details the terms, pricing, historical transaction amounts, and annual caps for these agreements, and explains the Listing Rules implications. This type of disclosure is a standard regulatory requirement for listed companies in Hong Kong when entering into agreements with connected parties. Since it does not fit into specific categories like M&A (TAR) or Share Issues (SHA), and is a formal regulatory disclosure, it is classified as a Regulatory Filing (RNS).
2026-03-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2026
Share Issue/Capital Change Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, share capital, and treasury shares. It does not fit into specific categories like 'Share Issue' (SHA) or 'Transaction in Own Shares' (POS) because it is a recurring, comprehensive regulatory filing covering all movements, and it is not an announcement of a report (RPA). Therefore, it is classified under the fallback category for regulatory filings.
2026-03-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2026
Regulatory Filings Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for companies listed on the HKEX to report monthly movements in securities, share capital, and treasury shares. It does not fit into specific categories like 'Annual Report' or 'Earnings Release' but is a mandatory periodic regulatory filing. Therefore, it is classified as a Regulatory Filing (RNS).
2026-02-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.